Mahmud Azra, Feely John
Department of Therapeutics and Hypertension Clinic, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.
Am J Hypertens. 2005 Dec;18(12 Pt 1):1543-8. doi: 10.1016/j.amjhyper.2005.06.014.
Adiponectin, an anti-inflammatory adipocytokine, is reduced in hypertension, diabetes, and coronary artery disease (CAD). Arterial stiffness, as aortic pulse wave velocity (PWV) in hypertension and diabetes, and as augmentation index (AIx) in CAD, is independently associated with cardiovascular mortality. We explored the relationship between adiponectin and arterial stiffness in essential hypertension.
Seventy-six untreated patients, 34 women, aged 47 +/- 1 years, mean +/- SEM with essential hypertension, had blood pressure (BP), carotid-femoral PWV, AIx plasma adiponectin, and proinflammatory cytokine C-reactive protein (CRP) measured using ELISA technique after an overnight fast. Results were analyzed using univariate and multiple logistic regression analysis.
There was a significant positive relationship between log adiponectin and AIx (r = 0.33, P < .005) and plasma HDL-cholesterol (r = 0.40, P < .001). In contrast there were significant negative relationships with PWV (r = -0.24, P < .05), transit time (r = -0.37, P < .001), and pulse pressure amplification (r = -0.30, P < .005) in addition to waist circumference, waist-to-hip ratio, height, and weight. In a stepwise regression model, the independent predictors of AIx were heart rate, height, mean arterial pressure, age, and gender (R2= 0.69, P < .0001) with no contribution from adiponectin. However, for PWV (R2= 0.59, P < .0001) the independent determinants were mean arterial pressure, age, and adiponectin.
These results show a divergent relationship between adiponectin and arterial stiffness, negative for PWV, and positive for wave reflection (AIx). Anthropomorphic factors, particularly height, weight, and heart rate may influence the relationship to the latter. Adiponectin is an independent predictor of aortic PWV but not of AIx.
脂联素是一种抗炎性脂肪细胞因子,在高血压、糖尿病和冠状动脉疾病(CAD)中水平降低。动脉僵硬度,如高血压和糖尿病中的主动脉脉搏波速度(PWV)以及CAD中的增强指数(AIx),与心血管死亡率独立相关。我们探讨了原发性高血压患者脂联素与动脉僵硬度之间的关系。
76例未经治疗的原发性高血压患者,其中34例女性,年龄47±1岁,平均±标准误。经过一夜禁食后,使用ELISA技术测量血压(BP)、颈股PWV、AIx、血浆脂联素和促炎细胞因子C反应蛋白(CRP)。结果采用单因素和多因素逻辑回归分析。
log脂联素与AIx(r = 0.33,P < 0.005)和血浆高密度脂蛋白胆固醇(r = 0.40,P < 0.001)之间存在显著正相关。相比之下,除了腰围、腰臀比、身高和体重外,脂联素与PWV(r = -0.24,P < 0.05)、传输时间(r = -0.37,P < 0.001)和脉压放大(r = -0.30,P < 0.005)之间存在显著负相关。在逐步回归模型中,AIx的独立预测因素是心率、身高、平均动脉压、年龄和性别(R2 = 0.69,P < 0.0001),脂联素无贡献。然而,对于PWV(R2 = 0.59,P < 0.0001),独立决定因素是平均动脉压、年龄和脂联素。
这些结果表明脂联素与动脉僵硬度之间存在不同的关系,对PWV为负相关,对波反射(AIx)为正相关。人体测量因素,特别是身高、体重和心率可能影响与后者的关系。脂联素是主动脉PWV的独立预测因素,但不是AIx的独立预测因素。